Table 1.
Demography of Intervention
| Characteristic | Operative Treatment (n=48) |
Conservative Treatment (n=379) |
p-Value |
|---|---|---|---|
| Gender (no. of fractures) | |||
| Female | 37 (77.1%) | 315 (83.1%) | |
| Male | 11 (22.9%) | 64 (16.9%) | 0.301 |
| Age *(yr) | 58.6 (SD 15.8) | 62.8 (SD 17.2) | 0.106 |
| Side of the fracture (no. of fractures) | |||
| Right | 21(43.8%) | 173 (45.6%) | |
| Left | 27 (56.3%) | 206 (54.4%) | 0.804 |
| Dominance (no. of fractures) | |||
| Yes | 25 (52.1%) | 174 (46%) | |
| No | 23 (47.9%) | 204 (54%) | 0.429 |
| Fracture type (no. of fractures) | |||
| 23-A | 16(33.3%) | 215 (56.7%) | |
| 23-B | 4 (8.3%) | 86 (22.7%) | |
| 23-C | 28 (58.3%) | 78 (20.6%) | 0.000 |
| Dislocation (no. of fractures) | |||
| Yes | 47 (97.9%) | 237 (62.5%) | |
| No | 1 (2.1%) | 142 (37.5%) | 0.000 |
| Reduction (no. of fractures) | |||
| Yes | 45 (93.8%) | 217 (57.3%) | |
| No | 3 (6.3%) | 162 (42.7%) | 0.000 |
| Cast-related complaints (no. of fractures) | 10 (27%) | 87 (23.2%) | 0.601 |
| Prevention (no. of fractures) | |||
| Placebo | 11 (22.9%) | 88 (23.2%) | |
| Vitamin C 200mg | 10 (20.8%) | 86 (22.7%) | |
| Vitamin C 500mg | 15 (31.3%) | 99 (26.1%) | |
| Vitamin C 1500mg | 12 (25%) | 106 (28%) | |
| Vitamin C overall | 37 (77.1%) | 291 (76.8%) | 0.891 |
| CRPS (no. of fractures) | |||
| Yes | 1 (2.1%) | 17 (4.5%) | |
| No | 47 (97.9%) | 362 (95.5%) | 0.707 |
*
The values are given as the mean of the standard deviation.